Acumen Pharmaceuticals Stock Pattern Recognition Two Crows

ABOS Stock

USD 3.27 -0.03 -0.91%

Use the pattern recognition workspace to apply Two Crows recognition and other studies to Acumen Pharmaceuticals. The analysis highlights pattern recognition signals tied to momentum and continuation and frames technical signals with volatility and risk context.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of forty-nine. The function did not return any valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for Acumen Pharmaceuticals.

Acumen Pharmaceuticals Technical Analysis Modules

Most technical analysis of Acumen Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Acumen from various momentum indicators to cycle indicators. When you analyze Acumen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimers disease. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia. Acumen Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. This stock section frames Acumen Pharmaceuticals within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/B of 2.19. Acumen Pharmaceuticals has a market cap of 204.13 M, ROE of -85.93%.

Methodology

Unless otherwise specified, financial data for Acumen Pharmaceuticals is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Acumen (USA Stocks:ABOS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information presented is compiled from public filings and market reference sources and official institutions such as U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Updates can be delayed depending on reporting conventions. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Acumen Pharmaceuticals is covered by 6 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Morgan Stanley, Goldman Sachs, Citigroup, Raymond James, Deutsche Bank, Evercore ISI, Guggenheim Securities, UBS Investment Research, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Acumen Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Acumen Pharmaceuticals' short interest history, or implied volatility extrapolated from Acumen Pharmaceuticals options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Driverless Cars Invested few shares	Go
	Warren Buffett Holdings Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Blockchain Invested few shares	Go
	Artificial Intelligence Invested few shares	Go
	Impulse Invested over 200 shares	Go
	ESG Investing Invested few shares	Go
	Investor Favorites Invested few shares	Go
	Hedge Favorites Invested over 20 shares	Go
	Momentum Invested few shares	Go

Additional Tools for Acumen Stock Analysis

	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Stocks Directory Find actively traded stocks across global markets
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC